Image below from Healius FY22 presentation. non-covid revenue was down on FY21.
Image below from ACL FY22 presentation. Non-covid revenue up 8% on FY21.
Market overreacting on HLS poor result. Obviously ACL wont produce the revenue & profits it did in FY22 but i think this is baked into the price & should pop on 1HY results. Let's see!!
target price and why, page-14
Add ACL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.61 |
Change
-0.010(0.38%) |
Mkt cap ! $528.8M | |||
| Open | High | Low | Value | Volume |
| $2.58 | $2.62 | $2.55 | $227.1K | 87.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 4999 | $2.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.61 | 1948 | 3 |
View Market Depth
| Last trade - 11.44am 25/06/2024 (20 minute delay) ? |
| ACL (ASX) Chart |